Search Results - "van Lijnschoten, I. G"
-
1
Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk (“ugly”) locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)
Published in BMC cancer (06-09-2022)“…Abstract Background The presence of mesorectal fascia (MRF) invasion, grade 4 extramural venous invasion (EMVI), tumour deposits (TD) or extensive or bilateral…”
Get full text
Journal Article -
2
Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk
Published in BMC cancer (06-09-2022)“…Background The presence of mesorectal fascia (MRF) invasion, grade 4 extramural venous invasion (EMVI), tumour deposits (TD) or extensive or bilateral…”
Get full text
Journal Article